Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis
Open Access
- 1 July 2000
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 69 (1) , 25-28
- https://doi.org/10.1136/jnnp.69.1.25
Abstract
OBJECTIVES Clinical reports have speculated on a more severe course of multiple sclerosis in patients with the apolipoprotein E (apoE) ε4 allele. As this could be reflected by differences in the severity of tissue damage MRI was used to obtain further support for a disease modifying effect of the apoE genotype. METHODS Brain MR scans of 83 patients (mean age 35.5 (SD 9.5 years) who participated in a cross sectional study on the distribution of genotype patterns in multiple sclerosis. The total lesion load on proton density weighted (T2-LL) and T1 weighted scans (T1-LL) obtained with conventional spin echo sequences at 1.5 T was measured. A “black hole” ratio ((T1-LL/T2-LL)×100) was also calculated. This indicates the proportion of multiple sclerosis lesions with more severe tissue damage and may reflect disease aggressiveness or quality of repair. RESULTS Patients with the apoE-ε3/ε4 genotype (n=19) showed a non-significantly greater T2-LL (16.0 (SD 14.0) cm3) than patients with the ε2/ε3 (n=11; 13.3 (9.5) cm3) or the ε3/ε3 genotype (n=49; 9.4 (SD 9.2) cm3). Both the T1-LL (2.6 (SD 3.3)v 1.6 (SD 2.4) and 1.2 (SD 3.0) cm3; p=0.04) and the black hole ratio (14.3 SD 11.9)v 7.4 (SD 9.3) and 8.4 (SD 13.3)%; p=0.02), however, were significantly higher in ε3/ε4 patients. Similar differences were seen when comparing patients with at least one ε4 allele with the remainder of the group. CONCLUSIONS These data support speculations on a modulation of multiple sclerosis severity by the apoE genotype which can be attributed to more extensive tissue destruction or less efficient repair in carriers of the ε4 allele.Keywords
This publication has 22 references indexed in Scilit:
- Evidence for genetic basis of multiple sclerosisThe Lancet, 1996
- Correlating MRI and clinical disease activity in multiple sclerosisNeurology, 1995
- Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's diseaseMolecular and Cellular Probes, 1994
- The epidemiology of multiple sclerosis: A general overviewAnnals of Neurology, 1994
- Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in VitroScience, 1994
- Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.Journal of Lipid Research, 1990
- A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.Journal of Clinical Investigation, 1989
- IMPAIRMENT AND RECOVERY OF IPSILATERAL SENSORY-MOTOR FUNCTION FOLLOWING UNILATERAL CEREBRAL INFARCTIONBrain, 1989
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983